The Emerging Crisis of Stakeholders in Implant-based Augmentation Mammaplasty in Korea.

Journal of Korean medical science 2020 Vol.35(15) p. e103

Kim JH, Paik NS, Nam SY, Cho Y, Park HK

관련 도메인

Abstract

[BACKGROUND] Korea is no longer safe from the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL); the first reported case was a Korean woman in her 40s who had a 7-year-history of receiving an implant-based augmentation mammaplasty using a textured implant. We conducted this study to discuss the emerging crisis of stakeholders in implant-based augmentation mammaplasty and to propose a multi-disciplinary approach to early detection of its complications.

[METHODS] We analyzed medical examination data that was collected from patients who visited us between August 12 and September 27, 2019. We evaluated a total of 114 women (n = 114) in the current study. They were evaluated for whether they were in healthy condition. Moreover, their baseline characteristics were also examined; these included age, gender, height (cm), weight (kg), duration since surgery (years), possession of a breast implant card, the site of surgical incision, side of symptoms and reasons for outpatient visit. Furthermore, the patients were also evaluated for their subjective awareness of the manufacturer, surface and shape of the breast implant. Potential complications include malrotation, folding, seroma, capsule thickening, upside-down rotation, rupture, capsule mass and breast mass.

[RESULTS] A majority of the patients had a past history of receiving textured implants. The corresponding percentage was 78.95% (90/114) and 85.09% (97/114) based on their subjective awareness of a breast implant and sonographic findings, respectively. That is, it was slightly increased with the use of a breast ultrasound.

[CONCLUSION] Here, we propose the following approaches. First, patient data should be prospectively collected. By tracking outcomes and complications of an implant-based augmentation mammaplasty, both high-quality care and patient safety can be ensured. Second, stakeholders in implant-based augmentation mammaplasty should collaborate with customers and regulatory authorities. Third, surgeons should consider applying imaging modalities for early detection of postoperative complications.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 6
시술 mammaplasty 유방성형술 dict 5
합병증 seroma 장액종 dict 1
합병증 anaplastic large cell lymphoma 보형물연관 역형성대세포림프종 dict 1
합병증 bia-alcl 보형물연관 역형성대세포림프종 dict 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] A scispacy 1
질환 breast implant-associated anaplastic large cell lymphoma C4528210
Breast implant-associated anaplastic large-cell lymphoma
scispacy 1
질환 breast implant C0178391
breast implant procedure
scispacy 1
질환 malrotation C0221210
Congenital malrotation of intestine
scispacy 1
질환 rupture C3203359
Rupture
scispacy 1
질환 capsule scispacy 1
기타 patients scispacy 1
기타 women scispacy 1
기타 patient scispacy 1
기타 implant-based scispacy 1

MeSH Terms

Adult; Breast; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Mammaplasty; Middle Aged; Republic of Korea; Ultrasonography; Young Adult

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문